Ireland has one of the highest incidences of cancer in the Western World. Each year approximately over 20,000 new cases are diagnosed (this figure is likely to rise to 40,000 by 2020). Every year 11,000 people die from the disease. Dr. John Kennedy (St. James Hospital) leads a voluntary co-ordinated research group (ICORG) with consultants, clinicians and researchers who organise clinical drug trials in Ireland.
The ‘take up’ of these trials is higher per capita in Ireland than even the USA and drug companies are taking note. It’s quite clear that advances in cancer research could not happen without the patients who volunteer for clinical trials, and we tell the story of one such patient, Marie Loughney.
Two Irish scientists working at the forefront of cancer research are Professor Tom Cotter of UCC and Dr. Rob O’Connor of DCU. Professor Cotter’s research into the body’s biochemical pathways led to the development of a drug which is 95% successful in the treatment of a rare form of leukaemia. While Dr. Rob O’Connor’s pioneering research into combining pre-existing drugs to devise new treatments for melanoma are brought to trial stage via ICORG.
Featuring: John Kennedy, Professor Tom Cotter, Dr. Rob O’Connor
Interviews: Professor John Crowne, Dr. Brian Moulton, Denis Slaman UCLA,